Dr. Edward Paul answers the question: 'How Does Chronic Pain Differ From Acute?' — -- Question: What Is Chronic Pain And How Does It Differ From Acute Pain? Answer: Chronic pain and acute pain ...

LTG-001 demonstrated rapid absorption with a Tmax of approximately 1.5 hours. The Food and Drug Administration (FDA) has granted Fast Track designation to LTG-001 for the treatment of acute pain.

Pain has the potential to affect various aspects of a person’s life, from disrupting one’s daily routine to negatively impacting emotional well-being. It’s also one of the most common reasons that ...

For pediatric nonoperative fractures and sprains, adding acetaminophen or hydromorphone to ibuprofen does not provide better ...

A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...

Editor’s Note (1/31/25): The U.S. Food and Drug Administration has approved the novel nonopioid medication suzetrigine for acute pain. That pain ranges from moderate to severe. The drug was tested in ...

USA: Researchers have found in a new study that in adults with acute and subacute low back pain, a biopsychosocial-oriented ...

The FDA approved prescription suzetrigine (Journavx) 50 mg oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults, the agency announced Thursday.

Approximately 7.6 million individuals in the United States suffer from opioid use disorder (OUD). Three evidence-based medications—methadone, buprenorphine, and naltrexone—are recommended for use by ...

With the world in an opioid crisis, the development of non-opioid analgesics has become more urgent. A series of Phase 3 clinical trials into a novel oral, non-opioid painkiller has found that it’s ...

After the FDA's landmark approval of the opioid-free acute pain reliever Journavx in January, Vertex Pharmaceuticals has hit a snag on its path to expand the potential blockbuster’s reach into ...

A neural circuit hidden in an understudied region of the brain plays a critical role in turning temporary pain into pain that ...